Jeff Hutchins

Jeff Hutchins

No más puestos en curso
67 años
Health Technology
Consumer Services

Perfil

Jeff T.
Hutchins
worked as a Director of Monoclonal Antibody Development at Glaxo Wellcome, Inc. from 1991 to 2007.
He then worked as a Vice President of Preclinical Research at Avid Bioservices, Inc. from 2012 to 2016.
He also held the position of Vice President of Preclinical Development at Inhibitex LLC.
Later, he worked as the Chief Operating & Scientific Officer at Scorpius Holdings, Inc. from 2017 to 2020.
He also worked as a Senior Vice President at Pelican Therapeutics, Inc. Dr. Hutchins received his undergraduate degree from Oral Roberts University and his doctorate from The University of Texas Health Science Center at Houston.

Antiguos cargos conocidos de Jeff Hutchins.

EmpresasCargoFin
SCORPIUS HOLDINGS, INC. Director de Operaciones 31/12/2020
AVID BIOSERVICES, INC. Corporate Officer/Principal 01/12/2016
Corporate Officer/Principal 01/01/2007
Corporate Officer/Principal -
Corporate Officer/Principal -
Ver el detalle de la experiencia de Jeff Hutchins.

Formación de Jeff Hutchins.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

41

Relaciones de 1er grado

7

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas7

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services